Patents by Inventor Rajan Goel

Rajan Goel has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8748457
    Abstract: The present invention is related to novel 2-Amino-2-[8-(dimethyl carbamoyl)-8-aza-bicyclo[3.2.1]oct-3-yl]-exo-ethanoyl derivatives of the general formula (A), their tautomeric forms, their stereoisomers, their pharmaceutically acceptable salts, pharmaceutical compositions containing them, methods of making of the above compounds, and their use as Dipeptidyl Peptidase-IV (DPP-IV) Inhibitors, which are useful in the treatment or prevention of diseases particularly Type II diabetes, other complications related to diabetes and other pathogenic conditions in which DPP IV enzyme is involved.
    Type: Grant
    Filed: September 1, 2009
    Date of Patent: June 10, 2014
    Assignee: Lupin Limited
    Inventors: Neelima Sinha, Prathap Nair, Navnath Karche, Nabendu Saha, Rajan Goel, Rajender Kumar Kamboj
  • Patent number: 8338450
    Abstract: The present invention is related to novel compounds of the general formula A, their tautomeric forms, their stereoisomers, their pharmaceutically acceptable salts, pharmaceutical compositions containing them, methods of making of the above compounds, and their use as Dipeptidyl Peptidase-IV (DPP-IV) Inhibitors, which are useful in the treatment or prevention of diseases particularly Type II diabetes, other complications related to diabetes and other pathogenic conditions in which DPP IV enzyme is involved.
    Type: Grant
    Filed: September 19, 2008
    Date of Patent: December 25, 2012
    Assignee: Lupin Limited
    Inventors: Sudershan Arora, Neelima Sinha, Prathap Nair, Sai Kumar Chakka, Anil Hajare, Azmi Reddy, Pravin Patil, Majid Sayyed, Rajender Kumar Kamboj, K. H. Sreedhara Swamy, Rajan Goel
  • Publication number: 20120082635
    Abstract: The present invention is related to novel 2-Amino-2-[8-(dimethyl carbamoyl)-8-aza-bicyclo[3.2.1]oct-3-yl]-exo-ethanoyl derivatives of the general formula (A), their tautomeric forms, their stereoisomers, their pharmaceutically acceptable salts, pharmaceutical compositions containing them, methods of making of the above compounds, and their use as Dipeptidyl Peptidase-IV (DPP-IV) Inhibitors, which are useful in the treatment or prevention of diseases particularly Type II diabetes, other complications related to diabetes and other pathogenic conditions in which DPP IV enzyme is involved.
    Type: Application
    Filed: September 1, 2009
    Publication date: April 5, 2012
    Applicant: LUPIN LIMITED
    Inventors: Neelima Sinha, Prathap Nair, Navnath Karche, Nabendu Saha, Rajan Goel, Rajender Kumar Kamboj
  • Publication number: 20100291020
    Abstract: The present invention is related to novel compounds of the general formula A, their tautomeric forms, their stereoisomers, their pharmaceutically acceptable salts, pharmaceutical compositions containing them, methods of making of the above compounds, and their use as Dipeptidyl Peptidase-IV (DPP-IV) Inhibitors, which are useful in the treatment or prevention of diseases particularly Type II diabetes, other complications related to diabetes and other pathogenic conditions in which DPP IV enzyme is involved.
    Type: Application
    Filed: September 19, 2008
    Publication date: November 18, 2010
    Applicant: Lupin Limited
    Inventors: Sudershan Arora, Neelima Sinha, Prathap Nair, Sai Kumar Chakka, Anil Hajare, Azmi Reddy, Pravin Patil, Majid Sayyed, Rajender Kumar Kamboj, K.H. Sreedhara Swamy, Rajan Goel
  • Publication number: 20050249831
    Abstract: A pharmaceutical composition comprising a herbal extract, comprising a mixture of saponins prepared from the pericarp of Sapindus trifoliatus, with binding affinities for the receptor sites viz. GABA-A agonist site, Glutamate-AMPA site, Glutamate-Kainate site, Glutamate-NMDA agonistic site, Glutamate-NMDA glycine (strychnine insensitive) site and Sodium channel (site 2), having major mediatory role in anticonvulsant activity. A process for preparation of the herbal extract; isolation of six pure compounds from the mixture of saponins in the aqueous extract; and a pharmaceutical composition comprising the said extract in combination with pharmaceutically acceptable additives. A method of prophylactic treatment of migraine through anticonvulsant activity of the composition by its administration through intranasal route.
    Type: Application
    Filed: August 27, 2003
    Publication date: November 10, 2005
    Applicant: LUPIN Ltd.
    Inventors: Sudershan Arora, Vandita Srivastava, Veeranjaneyulu Addepalli, Sridhar Natesan, Rajan Goel